Rare Disease Catalyst Report: Non-Oncology Pipeline & Milestones: October 2026
Shionogi bought into Niemann-Pick type C for $2bn. Beren’s rival faces the FDA on 17 November, and Rafael’s has just filed.
Catalyst
What is coming: PDUFA, CHMP, approvals, designations.